REPCF News 0.6600 Replicel Life Sciences Inc (REPCF)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Replicel Life Sciences Inc (REPCF) 0.6600 $REPCF

RepliCel Reports 2013 Annual Financial Results
Marketwire - Tue Mar 18, 7:04AM CDT
RepliCel Life Sciences Inc. (TSX VENTURE: RP)(OTCQB: REPCF), a clinical stage regenerative medicine company focused on the development of autologous cell therapies, today reported financial results for the year ended December 31, 2013.

RepliCel to Present RCH-01 Phase 1 Clinical Data at the 13th Congress of the Japanese Society for Regenerative Medicine
Marketwire - Thu Feb 27, 7:05AM CST
RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX VENTURE: RP) announced that its Director of Research and Development, Dr. Hisae Nakamura, and its Chief Medical Officer, Dr. Kevin McElwee, will be presenting at the 13th Congress of the Japanese Society for Regenerative Medicine to be held March 4-6, 2014 in Kyoto, Japan. An oral presentation of Phase 1 clinical data for RCH-01 is scheduled for March 5, 2014 between 3-5 p.m. local time.

RepliCel Retains Ubika Communication for Online Capital Market Exposure
Marketwire - Wed Feb 26, 4:01PM CST
RepliCel Life Sciences Inc. (TSX VENTURE: RP)(OTCQB: REPCF), today announced that it has retained Ubika Communication, a division of Ubika Corporation, to provide capital market exposure. Ubika offers capital market exposure services via their flagship website portal smallcapower.com (SCP) which is also featured on the Financial Post website. SCP represents a unique way for small cap companies to bridge between the traditional investor relations business model and the online world that is becoming increasingly important for maximizing shareholder value.

Androgenic Alopecia - Pipeline Review, H2 2013
M2 - Fri Feb 07, 3:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/567n76/androgenic) has announced the addition of the "Androgenic Alopecia - Pipeline Review, H2 2013" report to their offering. This report provides information on the therapeutic development for Androgenic Alopecia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Androgenic Alopecia. Androgenic Alopecia - Pipeline Review, Half Year is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Scope - A snapshot of the global therapeutic scenario for Androgenic Alopecia. - A review of the Androgenic Alopecia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Androgenic Alopecia pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - News and deals relating to the products. Reasons to Buy - Identify and understand important and diverse types of therapeutics under development for Androgenic Alopecia. - Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. - Plan mergers and acquisitions effectively by identifying players of the most promising pipeline. - Devise corrective measures for pipeline projects by understanding Androgenic Alopecia pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline. Companies Mentioned - Allergan - Histogen - Hygeia Therapeutics - Kasiak Research - Polichem - R-Tech Ueno - RepliCel Life Sciences - SWITCH Biotech - Samumed For more information visit http://www.researchandmarkets.com/research/567n76/androgenic About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.

Eurasian Minerals Announces Royalty Interests on Timok Joint Venture Copper-Gold Properties in Serbia
Marketwire - Tue Feb 04, 6:01AM CST
Eurasian Minerals Inc. (TSX VENTURE: EMX)(NYSE MKT: EMXX) (the "Company" or "EMX" is pleased to announce the acquisition of an uncapped 0.5% net smelter return ("NSR" royalty covering Reservoir Minerals Inc.'s ("Reservoir" or "RMC" share of minerals and metals mined from the "Brestovac" and "Jasikovo East" properties in Serbia. These properties occur in the Timok Magmatic Complex, and are included in the Timok Project joint venture between Reservoir (45%) and Freeport-McMoRan Exploration Corp. ("Freeport" (55%). The Brestovac property hosts porphyry and epithermal copper-gold mineralization at the Cukaru Peki discovery, and the Jasikovo East property occurs to the north in the Timok copper-gold belt. Reservoir recently announced an initial NI 43-101 compliant resource estimate for the Cukaru Peki deposit. EMX congratulates Reservoir and Freeport on achieving this important milestone, as well as their continuing Timok Project exploration successes.

RepliCel Receives Japanese Patent Covering its Hair Regeneration Technology
Marketwire - Mon Jan 13, 7:02AM CST
RepliCel Life Sciences Inc. (TSX VENTURE: RP)(OTCQB: REPCF) today announced that it has been granted a patent by Japan's Ministry of International Trade and Industry for hair follicle mesenchymal stem cells and their use thereof. These cells are used in RepliCel's RCH-01 treatment for androgenetic alopecia, also known as pattern hair loss. With the issuance of this patent, RepliCel now has patents issued in Japan, the United States, Australia and the European Union protecting its technology with other jurisdictions still pending.

CSE: 2014-0106-Delist-RepliCel Life Sciences Inc. (RP)
Marketwire - Thu Jan 09, 9:18AM CST
At the request of the Company, the common shares of RepliCel Life Sciences Inc. will be delisted at the market close Friday, January 10, 2014. RepliCel will continue to trade on the TSX Venture Exchange.

RepliCel to Commence Trading on the TSX Venture Exchange
Marketwire - Thu Jan 09, 7:02AM CST
RepliCel Life Sciences Inc. (OTCQB: REPCF)(CNSX: RP) is pleased to announce that its common shares are anticipated to commence trading on the TSX Venture Exchange (the "TSXV" on January 13, 2014 as a Tier 1 issuer. RepliCel will trade under its current trading symbol "RP". To ensure continued and seamless trading for RepliCel's shareholders, RepliCel's common shares will be delisted from the Canadian Securities Exchange at the close of trading on January 10, 2014 and will commence trading on the TSXV at market open on January 13, 2014.

RepliCel Life Sciences to Present at Biotech Showcase(TM) 2014
Marketwire - Thu Jan 09, 6:50AM CST
RepliCel Life Sciences Inc. (OTCQB: REPCF)(CNSX: RP), a clinical stage biopharmaceutical company focused on developing therapies to address conditions associated with cellular deficits, today announced that CEO David Hall will present at the Biotech Showcase(TM) 2014 investor and partnering conference to be held January 13-15, 2014 in San Francisco, at the Parc 55 Wyndham Hotel. Mr. Hall will discuss RepliCel's autologous cell therapies for treating tendinosis and androgenetic alopecia at 2:30 p.m. PST on January 13, 2014. A copy of the presentation will be added to RepliCel's website and can be viewed here once posted.

Replicel Announces Conditional Approval from TSX Venture Exchange
Marketwire - Thu Jan 02, 7:01AM CST
RepliCel Life Sciences Inc. (the "Company" or "RepliCel" (OTCQB: REPCF) (CNSX: RP) is pleased to announce that it has received conditional approval from the TSX Venture Exchange (the "TSXV" for the listing of its common shares on the TSXV. The listing is subject to the Company fulfilling certain requirements of the TSXV in accordance with the terms of the conditional approval. Upon obtaining final approval, the Company will issue a further press release to update when it anticipates its common shares will commence trading on the TSXV. In connection with the Company's listing on the TSXV, the Company anticipates that 23,509,682 shares of its common stock (each, a "Share" , which represents approximately 49% of the Company's issued and outstanding shares, will be escrowed, with 25% of the escrowed Shares being released upon listing and a further 25% every six months. In addition, stock options to acquire upto1,400,000Shareswill also be subject to escrow under the same release schedule.

RepliCel Reports Progress on Shiseido Technology Transfer for RCH-01 Treatment for Pattern Baldness
Marketwire - Thu Dec 19, 7:02AM CST
RepliCel Life Sciences Inc. (OTCQB: REPCF)(CNSX: RP) today reported on the progress of its technology transfer agreement with its partner, Shiseido Company, Limited.

RepliCel Reports Third Quarter 2013 Financial Results and Provides Corporate Update
Marketwire - Wed Nov 20, 7:02AM CST
RepliCel Life Sciences Inc. (OTCQB: REPCF)(CNSX: RP), a clinical stage regenerative medicine company focused on the development of autologous cell therapies, today reported financial results for the third quarter and nine months ended September 30, 2013.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MegaRobo's Nearly $200 Million Bet on Learning Labs

Updated Category News Views 41

A lab robot that merely follows instructions is old news; a system that learns from the mess it makes is the expensive part. MegaRobo has raised nearly US$200 million to push toward that harder prize: infrastructure that links AI reasoning to actual experiments, instruments, automation and the results that come back. For investors watching AI for Science, this is more...

Continue Reading
AutoMobility LA Puts 2028 Mobility on Center Stage

Updated Category News Views 98

Los Angeles is cramming an awful lot of automotive ambition into one Thursday. AutoMobility LA opens November 19 at the Los Angeles Convention Center, one day before the LA Auto Show begins its November 20–29 public run. Yes, there will be coffee carts, awards, creators and the usual event confetti. But beneath that polished show-floor racket sits a fairly serious...

Continue Reading
Freedom Debt Relief Earns Service Recognition in 2026

Updated Category News Views 81

A Service Badge Carries Weight in a Rough Business Debt settlement is not a business where a pleasant phone voice alone gets the job done. People arrive carrying unsecured balances, anxiety, and usually a fair amount of distrust. That is why CNBC Select naming Freedom Debt Relief its “Best for Customer Service” is more meaningful than the usual chest-thumping...

Continue Reading
GomSpace's €8M Lunar Deal Pushes Mission Ambitions

Updated Category News Views 13

Moon hardware is where small-space dreams either grow teeth or chew through cash, and GomSpace has just taken another meaningful bite. The company has secured an €8 million, or 89.1 million Swedish kronor, contract for the second phase of a lunar mission program with an unnamed leading North American space company. For GOMX, this is not some vague laboratory...

Continue Reading
Zoomcar's November 23 Report Puts Execution on Trial

Updated Category News Views 0

A Date on the Board, Not a Verdict November 23 is when Zoomcar finally has to put some fresh numbers beside the story. The Bengaluru-based peer-to-peer car-sharing marketplace says it will release second-quarter fiscal 2027 financial and operating results that Monday, covering the quarter ended September 30, 2026. Management also plans a live webcast at 8:00 a.m. Eastern...

Continue Reading
Marelli’s Two Awards Put Practical Auto Tech in Focus

Updated Category News Views 161

Two trophies in Novi do not fill an order book, but Marelli’s latest pair says something useful about where automotive suppliers are trying to earn their keep. The company collected a 2026 Automotive News PACE Award for HorizonView and a PACE Pilot Award for Affordable 5G RedCap at the November 17 ceremony. One is already deployed in production; the other is a...

Continue Reading
Hitachi's Quiet Fusion Bet Is Really About Data Control

Updated Category News Views 88

Weeks of engineering work can vanish because one storage system hiccups, which is a rotten way to learn that data infrastructure belongs in the mission-critical column. Esteyco’s new environment, built with Hitachi Vantara and implemented by Quadrics Sistemas, is not a fusion breakthrough. It is the less glamorous machinery that keeps serious fusion research from...

Continue Reading
Dubai's 2028 Fire Congress Puts Global Safety Tech on Stage

Updated Category News Views 14

Fire engines, wildfires, dense towers, and AI are all colliding in Dubai's next big public-safety moment. The World Fire Congress has handed its 2028 host role to Dubai, making this the first time the biennial gathering of global fire and emergency-service leaders will land in the Middle East. That is not a quarterly earnings event, and nobody ought to pretend it is....

Continue Reading
Vector Adds Mesa Division 10 Veteran for Arizona Growth

Updated Category News Views 111

A toilet-partition deal rarely raises eyebrows, but this one has the sturdy logic investors ought to notice. Vector Building Products has acquired Mesa-based Partitions & Accessories Co., a Division 10 specialist that has served Arizona contractors since 1978. It is not glamorous work. It is, however, the sort of necessary, specification-driven business that gets embedded...

Continue Reading
Fidelis Puts $140,000 Behind Statewide Postpartum Care

Updated Category News Views 125

A missed postpartum appointment can look like a small administrative failure until it is not. Fidelis Care’s $140,000 round of Here for Your Health maternal health grants is aimed squarely at that unglamorous but consequential gap: keeping new mothers connected to care after delivery, particularly in underserved New York communities. Small Dollars, Very Specific...

Continue Reading

Top 5 Most Recently Viewed Articles

374Water Initiates Groundbreaking AFFF Destruction Project

Updated Category News Views 118

374Water's Innovative AFFF Destruction Initiative 374Water Inc. (NASDAQ: SCWO), a leading company in organic waste destruction technology, has embarked on a significant contract with the state of North Carolina. This initiative aims to tackle a critical environmental concern: the destruction of Aqueous Film-Forming Foam (AFFF). This contract represents a key milestone not...

Continue Reading
Beary Landscaping Expands with Strategic Acquisition of Sun Valley

Updated Category News Views 268

Exciting New Partnership in Landscaping Services Beary Landscaping has announced its recent acquisition of Sun Valley Landscape and Snow, marking a significant step in enhancing its capabilities within the Midwest's competitive landscape services sector. This strategic partnership aims to ensure that Beary can provide exceptional landscaping and snow removal services to...

Continue Reading
FiscalNote Unveils Custom AI Tariff Reports to Enhance Trade Decisions

Updated Category News Views 140

Introducing AI-Powered Tariff Impact Reports by FiscalNote FiscalNote Holdings, Inc. (NYSE: NOTE), a renowned provider of AI-driven policy and regulatory intelligence solutions, has rolled out a new feature: personalized tariff impact reports. These reports, integrated into the tariff tracking tool launched earlier this year, allow organizations to quickly assess how...

Continue Reading
Exciting Upcoming Episodes of UNSCRIPTED with Dino Rizzo

Updated Category News Views 156

Upcoming Episodes of UNSCRIPTED with Dino Rizzo The Association of Related Churches (ARC) is thrilled to announce the release of new episodes of UNSCRIPTED, hosted by Dino Rizzo. This innovative series showcases meaningful conversations with church leaders who are significantly influencing their communities. Engaging Conversations with Influential Leaders UNSCRIPTED is...

Continue Reading
NETSOL Technologies Powers New Leasing Operations in Indonesia

Updated Category News Views 165

NETSOL Technologies Launches Transcend Finance Platform NETSOL Technologies, Inc. (Nasdaq: NTWK), based in Encino, California, has made a significant advancement in the asset finance and leasing sphere with the launch of its Transcend Finance platform for a prominent Chinese leasing company. This event represents a milestone for the customer, marking their official...

Continue Reading